Question 1

What is Instylla?

Accepted Answer

Instylla is a privately held, clinical-stage company focused on developing next-generation liquid embolics for interventional radiology, with initial clinical applications in interventional oncology and peripheral hemostasis.

Question 2

What are the key products or services offered by Instylla?

Accepted Answer

Instylla delivers next-generation liquid embolics for interventional radiology, with a focus on interventional oncology and peripheral hemostasis. The company is currently in the process of completing a pivotal study for their liquid embolic product for the treatment of hypervascular tumors.

Question 3

What is the status of Instylla's clinical development?

Accepted Answer

Instylla has recently announced the completion of patient enrollment in the ongoing Instylla HES Hypervascular Tumor Pivotal Study. This is a significant milestone for the company as they work towards bringing their liquid embolic product to market for the treatment of hypervascular tumors.

Question 4

Is Instylla's product available for purchase?

Accepted Answer

No, Instylla's product is currently investigational and limited by federal (or US) law to investigational use only. It is not available for sale at this time.

Question 5

What is the regulatory status of Instylla's product?

Accepted Answer

Instylla's product is currently in the investigational stage and undergoing clinical trials. The company's liquid embolic product is limited by federal (or US) law to investigational use only and is not yet available for commercial sale.

Instylla

Company Overview

Company Name

Address

Website

Phone

About Instylla

Frequently Asked Questions about Instylla

What is Instylla?

What are the key products or services offered by Instylla?

What is the status of Instylla's clinical development?

Is Instylla's product available for purchase?

What is the regulatory status of Instylla's product?

Technologies Used

Social Profiles

Key Decision Makers